VIETNAMPLUS

Quantitative research on proteins in vaccines in the Vabiotech laboratory (Source: VNA)

Havana (VNA) – The Finlay Vaccine Institute (IFV) of Cuba and the Vietnamese company Vabiotech agreed this Friday in Havana to strengthen ties in the field of biotechnology.

“A delegation from the Vietnamese company Vabiotech, led by its director, Nguyen Anh Tuan, visited the IFV. There was discussion about joint collaboration and future projects. The representatives of Vietnam received an update on the work of the Institution,” states a message from the Caribbean entity on the social network X.

“In the exchange between IFV and the Vietnamese company Vabiotech, the desire to continue expanding the links of collaboration between both biotechnology institutions was expressed,” the text underlines.

Vabiotech is one of the leading companies in Vietnam in the manufacturing, marketing, research and development of a wide range of vaccines, diagnostic kits, biological, therapeutic, and pharmaceutical products; cosmetics, food, in addition to the provision of health services.

Currently, Vabiotech produces four vaccines: Hepatitis B, Hepatitis A, Japanese Encephalitis and Oral Cholera, and also imports immunogens to combat mumps, rubella, meningococcus and chickenpox.

The IFV of Cuba has glycoconjugated, synthetic, combined, therapeutic and infectious disease injectables. The effects of these products in the control of epidemics such as the one caused by Neisseria meningitidis in 1989 in Cuba and was eradicated with the VA-MENGOC-BC are recognized.

A trivalent anti-leptospirosis vaccine was also obtained from inactivated cells of Lectospira interrogans (serovars Canicola canicola, Pomona mozdok and Icterohaemorrhagiae copenhageni) to combat outbreaks of leptospirosis, among other scientific achievements that largely guarantee the sovereignty of the nation in this field.

Previously, the Duc Minh Medical Joint Stock Company (Almedic) of Vietnam also signed supply agreements in Hanoi with the Center for Genetic Engineering and Biotechnology (CIGB) and the Center for Molecular Immunology (CIM), both Cuban.

Under the contracts, which are part of the cooperation and trade plan between Almedic and its partners in 2024, in addition to vaccines, CIMAher (a monoclonal antibody to treat head and neck, pancreatic and esophageal cancer) and the CIMVAx EGF (for treatment of lung cancer).

Almedic also cooperates with the Pasteur Da Lat vaccine company to produce a stage of Cuban vaccines in Vietnam and coordinates the sending of Vietnamese technicians and managers to biology centers and advanced laboratories in Cuba for short-term studies and training, as well as for bring Cuban experts to Vietnam to provide advice and training./.

2023-11-26 07:55:00
#Vietnam #Cuba #strengthen #ties #biotechnology #Vietnam

Havana (VNA) – The Finlay Vaccine Institute (IFV) of Cuba and the Vietnamese company Vabiotech agreed this Friday in Havana to strengthen ties in the field of biotechnology.

“A delegation from the Vietnamese company Vabiotech, led by its director, Nguyen Anh Tuan, visited the IFV. There was discussion about joint collaboration and future projects. The representatives of Vietnam received an update on the work of the Institution,” states a message from the Caribbean entity on the social network X.

“In the exchange between IFV and the Vietnamese company Vabiotech, the desire to continue expanding the links of collaboration between both biotechnology institutions was expressed,” the text underlines.

Vabiotech is one of the leading companies in Vietnam in the manufacturing, marketing, research and development of a wide range of vaccines, diagnostic kits, biological, therapeutic, and pharmaceutical products; cosmetics, food, in addition to the provision of health services.

Currently, Vabiotech produces four vaccines: Hepatitis B, Hepatitis A, Japanese Encephalitis and Oral Cholera, and also imports immunogens to combat mumps, rubella, meningococcus and chickenpox.

The IFV of Cuba has glycoconjugated, synthetic, combined, therapeutic and infectious disease injectables. The effects of these products in the control of epidemics such as the one caused by Neisseria meningitidis in 1989 in Cuba and was eradicated with the VA-MENGOC-BC are recognized.

A trivalent anti-leptospirosis vaccine was also obtained from inactivated cells of Lectospira interrogans (serovars Canicola canicola, Pomona mozdok and Icterohaemorrhagiae copenhageni) to combat outbreaks of leptospirosis, among other scientific achievements that largely guarantee the sovereignty of the nation in this field.

Previously, the Duc Minh Medical Joint Stock Company (Almedic) of Vietnam also signed supply agreements in Hanoi with the Center for Genetic Engineering and Biotechnology (CIGB) and the Center for Molecular Immunology (CIM), both Cuban.

Under the contracts, which are part of the cooperation and trade plan between Almedic and its partners in 2024, in addition to vaccines, CIMAher (a monoclonal antibody to treat head and neck, pancreatic and esophageal cancer) and the CIMVAx EGF (for treatment of lung cancer).

Almedic also cooperates with the Pasteur Da Lat vaccine company to produce a stage of Cuban vaccines in Vietnam and coordinates the sending of Vietnamese technicians and managers to biology centers and advanced laboratories in Cuba for short-term studies and training, as well as for bring Cuban experts to Vietnam to provide advice and training./.

2023-11-25 09:34:00
#Vietnam #Cuba #strengthen #ties #biotechnology #Vietnam

Illustration photo. (Source: baodautu.vn) Hanoi (VNA) – Vietnam is one of the countries that will participate in the tests of the Japanese vaccine against dengue, revealed Nguyen Van Kinh, vice president of the Vietnam Medical Association.

According to the official, to have a thorough evaluation of the impact of the vaccine, it is necessary to carry out tests before applying it widely in the community.

According to the Ministry of Health, from the beginning of the year until now, the country has registered more than 90 thousand cases of dengue, of which 26 are fatal.

Hanoi is one of the “hot” points in the country as the number of dengue cases continues to increase. In the first week of October, the Vietnamese capital reported almost 2,600 victims of the febrile illness, bringing the number of patients in this regard so far this year to almost 18,000.

Previously, some countries tested and licensed a vaccine to prevent dengue, but the effectiveness was not as expected, especially with dengue type 2 virus, which is the most popular today.

Recently, Japan produced an antiviral substance intended for both adults and children to prevent the disease, and the initial test showed its effectiveness in preventing the 4 types of dengue viruses.

According to the World Health Organization (WHO), febrile illness is classified as one of the 10 global health challenges, and up to 40% of the world’s population lives in areas at risk of dengue hemorrhagic fever infection.

It is estimated that dengue causes around 20 thousand deaths worldwide each year.

Treatment of dengue patients at Bach Mai Hospital, Hanoi. (Source: hanoimoi.com.vn)

The disease is caused by four serotypes of the dengue virus (DEN-1, DEN-2, DEN-3, DEN-4), of which DEN-1 and DEN-2 account for 90% of cases.

In particular, a second dengue infection is very dangerous because the condition is usually more serious than the first./.

2023-10-13 03:22:00
#Vietnam #participate #trials #Japanese #dengue #vaccine #Vietnam

Vaccination for children in Vietnam (Source: VNA) Hanoi (VNA) The National Institute of Hygiene and Epidemiology decided to allocate 185 thousand doses of the DPT-VGB-Hib vaccine to 49 cities and provinces within this month.

The vaccine helps protect children against diphtheria, pertussis, tetanus, hepatitis B, and haemophilus influenzae type b (Hib).

The doses are part of a batch of the vaccine financed by the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF), which arrived in Hanoi on July 27 to serve the expanded national program of immunization.

Previously, 72,300 doses were distributed to 14 northern mountainous provinces, using national funds.

Like other countries around the world, routine immunization services in Vietnam were disrupted during the COVID-19 pandemic, resulting in some 114,000 children under one year of age not receiving vaccinations against diphtheria, tetanus and pertussis, which are used as indicators of global immunization coverage, in 2022.

Furthermore, due to the recent shortage of the 5-in-1 vaccine, an estimated 300,000 Vietnamese children born in early 2023 have yet to receive this essential vaccine.

The WHO representative in Vietnam, Angela Pratt, said the organization will continue to work with UNICEF and other partners to support the Vietnamese government, ensuring that all children in all corners of the country receive full and timely vaccinations, both now and in the future. future./.

VNA

2023-08-16 03:28:00
#doses #5in1 #vaccine #distributed #locations #month #Vietnam